海外の治験の状況「前立腺癌」での検索結果
266件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
- Prostate Cancer Metastatic;C61 - Malignant neoplasm of prostate
- Australia, Belgium, Canada, Denmark, Estonia, France, Germany, Iceland, Israel, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2012-12-05
Not Recruiting
- A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined With Dasatinib to Docetaxel Combined With Placebo in Castration-Resistant Prostate Cancer
- Prostatic Neoplasms;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Greece, Hungary, India, Ireland, Italy, Korea, Republic of, Mexico, Norway, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, United Kingdom, United States
- 2012-10-18
Not recruiting
- A Pilot Study of patients with Oligometastases from Prostate cancer treated with Stereotactic Ablative Body Radiosurgery
- Metastatic Prostate Cancer (oligometastatic 1-3 metastases)
- Australia
- 2013-04-17
Not Recruiting
- A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects With Castration Resistant Prostate Cancer That Have Received Prior Treatment With Docetaxel
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Peru, Poland, Puerto Rico, Romania, Russian Federation, Spain, United Kingdom, United States
- 2015-11-12
Not Recruiting
- An International Field Study Of The Reliability And Validity Of The EORTC QLQ-C30 And A Disease-Specific Questionnaire Module (QLQ-PR25) For Assessing Quality Of Life Of Patients With Prostate Cancer
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Belgium, Denmark, France, Germany, Italy, Netherlands, Norway, Romania, Turkey, United Kingdom
- 2015-11-12
Not Recruiting
- A Phase III Trial to Test the Efficacy of ZD4054(Zibotentan), an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation, Serbia, Singapore, South Africa, Sweden, Switzerland, Taiwan, Province of China, United Kingdom, United States
- 2015-11-11
Not recruiting
- Sodium Valproate/Metformin Combination therapy for prostate cancer
- Prostate cancer
- Australia
- 2016-08-02
Not Recruiting
- Evaluating two decision aids for Australian men to support informed choice about prostate cancer screening
- prostate cancer;informed choice;overdiagnosis; prostate cancer br>informed choice overdiagnosis;Public Health - Health promotion/education;Cancer - Prostate
- Australia
- 2018-10-18
Not recruiting
- Radionuclide therapy using 177Lu-PSMA: a pilot study in men with castrate-resistant prostate cancer (LuPSMA trial)
- castrate-resistant prostate cancer
- Australia
- 2018-09-17
Not recruiting
- A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
- Prostate Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Chile, China, Czechia, France, Germany, Hong Kong, Israel, Italy, Mexico, New Zealand, Poland, Romania, Russian Federation, Singapore, Spain, Turkey, United Kingdom, United States
- 2019-09-20